Invention Grant
- Patent Title: Tricyclic heterocycles as bet protein inhibitors
-
Application No.: US15802142Application Date: 2017-11-02
-
Publication No.: US10227359B2Publication Date: 2019-03-12
- Inventor: Andrew P. Combs , Richard B. Sparks
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D498/06
- IPC: C07D498/06
Abstract:
The present disclosure relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20180222920A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Public/Granted day:2018-08-09
Information query
